+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "FDA Warning Letter"

Investigations and Corrective/Preventive Actions - Product Thumbnail Image

Investigations and Corrective/Preventive Actions

  • Training
  • 60 Minutes
  • Global
Learning from Laboratory-related FDA Warning Letters - Product Thumbnail Image

Learning from Laboratory-related FDA Warning Letters

  • Training
  • 90 Minutes
  • Global
Managing Failure Investigations and OOS Situations - Regulatory Requirements and Strategies for Implementation - Product Thumbnail Image

Managing Failure Investigations and OOS Situations - Regulatory Requirements and Strategies for Implementation

  • Training
  • 60 Minutes
  • Global
Acceptance Activities in FDA QSR - Product Thumbnail Image

Acceptance Activities in FDA QSR

  • Training
  • 90 Minutes
  • Global
Thorough and Complete Investigations and Follow-Up - A Current Regulatory Expectation - Product Thumbnail Image

Thorough and Complete Investigations and Follow-Up - A Current Regulatory Expectation

  • Training
  • 90 Minutes
  • Global
FDA Regulatory Actions: It's Not Just about Warning Letters - Product Thumbnail Image

FDA Regulatory Actions: It's Not Just about Warning Letters

  • Training
  • 60 Minutes
  • Global
FDA Warning Letter Closeout Program - Product Thumbnail Image

FDA Warning Letter Closeout Program

  • Training
  • 60 Minutes
  • Global
Implementing FDA's 21 CFR 111 for Dietary Supplements - Product Thumbnail Image

Implementing FDA's 21 CFR 111 for Dietary Supplements

  • Training
  • 75 Minutes
  • Global
Understanding the Current FDA Requirements for Raw Materials and Components - Product Thumbnail Image

Understanding the Current FDA Requirements for Raw Materials and Components

  • Training
  • 90 Minutes
  • Global
Coping with a Difficult Compliance Officer when Responding to a 483, Warning Letter, Import Alert or Recall - Product Thumbnail Image

Coping with a Difficult Compliance Officer when Responding to a 483, Warning Letter, Import Alert or Recall

  • Training
  • 60 Minutes
  • Global
Dietary Supplements and Nutraceuticals: Compliance with FDA's Current Manufacturing Requirements - Product Thumbnail Image

Dietary Supplements and Nutraceuticals: Compliance with FDA's Current Manufacturing Requirements

  • Training
  • 90 Minutes
  • Global
FDA Warning Letters - Stop Fumbling your Response and Effectively Demonstrate Compliance - Product Thumbnail Image

FDA Warning Letters - Stop Fumbling your Response and Effectively Demonstrate Compliance

  • Training
  • 60 Minutes
  • Global
Process Validation for Medical Devices - The Regulatory Approach - Product Thumbnail Image

Process Validation for Medical Devices - The Regulatory Approach

  • Training
  • 90 Minutes
  • Global
Validation of Existing/ Legacy Computer Systems for FDA/EU Compliance - Product Thumbnail Image

Validation of Existing/ Legacy Computer Systems for FDA/EU Compliance

  • Training
  • 75 Minutes
  • Europe
Medical Device Process Validation Training for Professionals - Product Thumbnail Image

Medical Device Process Validation Training for Professionals

  • Training
  • 90 Minutes
  • Global
Good Documentation Practice and Record Keeping Regulations (FDA & EMA) - Product Thumbnail Image

Good Documentation Practice and Record Keeping Regulations (FDA & EMA)

  • Training
  • 60 Minutes
  • Global
Validation Master Plan - The Unwritten Requirements - Product Thumbnail Image

Validation Master Plan - The Unwritten Requirements

  • Training
  • 60 Minutes
  • Global
Learning from Recent FDA Warning Letters Related to Part 11 and Computer Validation - Product Thumbnail Image

Learning from Recent FDA Warning Letters Related to Part 11 and Computer Validation

  • Training
  • 75 Minutes
  • Global
Transfer of Analytical Methods According to the USP Chapter <1224> - Product Thumbnail Image

Transfer of Analytical Methods According to the USP Chapter <1224>

  • Training
  • 75 Minutes
  • Global
FDA Computer System Validation Training: Pack of 6 Training Courses - Product Thumbnail Image

FDA Computer System Validation Training: Pack of 6 Training Courses

  • Training
  • 8 Hours
  • Global
Loading Indicator

The FDA Warning Letter market within the context of Pharmaceutical Manufacturing is a market that focuses on the enforcement of regulations and standards set by the U.S. Food and Drug Administration (FDA). Companies in this market are responsible for ensuring that their products meet the FDA's requirements for safety, efficacy, and quality. Companies must also comply with the FDA's Good Manufacturing Practices (GMPs) and other regulations. Companies that fail to meet these standards may receive a warning letter from the FDA, which can result in fines, product recalls, or other penalties. Companies in this market must also be aware of the latest developments in the industry, such as new regulations or changes to existing regulations. Some companies in the FDA Warning Letter market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. Show Less Read more